Reported Earlier, Nona Biosciences Enters Global License Agreement With AstraZeneca For Monoclonal Antibody Development
Reported Earlier, Nona Biosciences Enters Global License Agreement With AstraZeneca For Monoclonal Antibody Development
此前報道，Nona Biosciences與阿斯利康簽訂了單克隆抗體開發全球許可協議
Reported Earlier, Nona Biosciences Enters Global License Agreement With AstraZeneca For Monoclonal Antibody Development
此前報道，Nona Biosciences與阿斯利康簽訂了單克隆抗體開發全球許可協議
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。